| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Astria Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14.1K | Jun 5, 2024 | Direct | ||
| Landos Biopharma, Inc. | Director | Stock Option (right to buy) | 0 | May 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ATXS | Astria Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 6, 2024 | Director |
| LABP | Landos Biopharma, Inc. | May 23, 2024 | 3 | $0 | 4 | May 23, 2024 | Director |
| ATXS | Astria Therapeutics, Inc. | Jun 2, 2023 | 1 | $0 | 4 | Jun 6, 2023 | Director |
| LABP | Landos Biopharma, Inc. | May 23, 2023 | 1 | $0 | 4 | May 24, 2023 | Director |
| ATXS | Astria Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4/A | Jun 21, 2022 | Director |
| LABP | Landos Biopharma, Inc. | Jun 7, 2022 | 1 | $0 | 4 | Jun 9, 2022 | Director |
| LABP | Landos Biopharma, Inc. | May 16, 2022 | 1 | $0 | 4 | May 18, 2022 | Director |
| LABP | Landos Biopharma, Inc. | Aug 27, 2021 | 1 | $0 | 4 | Aug 31, 2021 | Director |
| LABP | Landos Biopharma, Inc. | Aug 27, 2021 | 0 | $0 | 3 | Aug 31, 2021 | Director |
| ATXS | CATABASIS PHARMACEUTICALS INC | Jun 2, 2021 | 1 | $0 | 4 | Jun 2, 2021 | Director |